Ischemic heart disease decisions — 2024

The Board has granted service connection for arteriosclerotic heart disease (coronary artery disease) prior to August 10, 2022, due to herbicide agent exposure on a facts-found basis under the PACT Act.

The Veteran's appeals for service connection were dismissed due to his withdrawal of the appeal.

The Veteran's appeals for service connection were dismissed due to the withdrawal of his appeal by his representative.

The Veteran's claim for a bilateral hearing loss disability is denied as he does not have a current disability for VA purposes.,The Veteran's claims for an acquired psychiatric disorder, diabetes mellitus, peripheral neuropathy (upper and lower extremities), erectile dysfunction, vestibular disability, skin condition, heart condition, and respiratory condition are remanded due to the need for further development of evidence.,The Veteran's claim for a bilateral kidney condition is remanded as it may be related to his service-connected diabetes mellitus.

The Board has granted service connection for pulmonary sarcoidosis and heart condition, including arrhythmia, bradycardia with right bundle branch block, cardiovascular symptoms, heart failure, and cardiac arrest, as secondary to the Veteran's service-connected pulmonary sarcoidosis.

The Board has denied service connection for coronary artery disease, heart disease, chest pain, shortness of breath, and fatigue as there is no evidence to support a nexus between these conditions and the Veteran's military service.

The Veteran's service-connected heart disability is rated at 100 percent effective November 29, 2016. The earlier effective date of November 29, 2016 for SMC based on aid and attendance is also granted.

The Board has remanded the Veteran's claims for an increased rating for a heart disability and TDIU due to duty-to-assist errors. The Veteran is also entitled to an initial 10 percent rating, but no higher, for his left chest scar.

The Veteran's claims for hypertension, angina, cardiomyopathy, and coronary artery disease were denied as there was no evidence of exposure to herbicide agents (Agent Orange) during service or a direct relationship to service.

The Veteran's claim for an evaluation in excess of 20 percent for right foot drop, neuropathy is denied. The Veteran's PTSD remains at a 70% rating from September 13, 2023.

The Veteran's TDIU was granted effective September 10, 2019, due to his service-connected PTSD and coronary artery disease preventing him from securing or following a substantially gainful occupation.,Eligibility for Chapter 35 Dependents' Educational Assistance based on the Veteran's permanent total service-connected disability (TDIU) was also granted effective September 10, 2019.

The Veteran's appeals for a higher rating for coronary artery disease, service connection for posttraumatic stress disorder, and service connection for embolism/infarction have been dismissed due to the Veteran's death. The appeal is not about service connection but rather about the level of disability.

The Veteran was granted service connection for coronary artery disease, Type II diabetes mellitus, and hypertension associated with herbicide agent exposure.,Service connection is granted for coronary artery disease, Type II diabetes mellitus, and hypertension under the PACT Act.

The Veteran's claims for service connection for bone cancer, lung cancer, prostate cancer, coronary artery disease, and bilateral hearing loss were denied as there was no evidence of in-service exposure to herbicide agents or other factors that would support presumptive service connection. The Board found the Veteran did not meet the second element of service connection due to lack of credible evidence supporting his assertions of in-service exposure.

The Board has decided to remand the claim of service connection for coronary artery disease due to a pre-decisional error in obtaining a VA examination and medical opinion. The Veteran's exposure to contaminated water at Camp Lejeune is considered, but further clarification on the relationship between his service-connected hyperlipemia and his coronary artery disease is needed.

The Veteran's claims for service connection for a heart condition and dyslipidemia are being remanded due to the need for additional medical opinions regarding the etiology of these conditions.

The Veteran's service connection claims for heart disease, cardiomyopathy, congestive heart failure, and diabetes mellitus have been granted. The TDIU claim is also remanded as it is inextricably intertwined with the rating decisions on these conditions.

The Board has granted service connection for type II diabetes mellitus, prostate cancer, and ischemic heart disease due to herbicide exposure in Blue Water service.

The Board denied the Veteran's claim for a higher rating for his coronary artery disease (CAD) and Wolff-Parkinson White Syndrome, finding that the evidence did not meet the criteria for a 100 percent disability rating.

The Veteran's appeals for increased ratings and service connection have been dismissed due to his death. The VA was notified of his death in March 2024.